Cited by 308Pancreatic function and diabetesDiabetes Treatment and ManagementGenetic Associations and Epidemiology

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms

Open access

Schäfer, S. A., Tschritter, O., Machicao, F., Thamer, C., Stefan, N., Gallwitz, B., Holst, J. J., Dekker, J. M., t’Hart, L. M., Nijpels, G., van Haeften, T. W., Häring, H. U., Fritsche, A.·2007·Diabetologia

DOI 10.1007/s00125-007-0753-6PMC PMC2063563

Open this paper in CoChat — free account Open PDF

Abstract

Aims/hypothesis Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes and reduced insulin secretion. The transcription factor TCF7L2 is an essential factor for glucagon-like peptide-1 (GLP-1) secretion from intestinal L cells. We studied whether a defect in the enteroinsular axis contributes to impaired insulin secretion in carriers of TCF7L2 polymorphisms.Methods We genotyped 1,110 non-diabetic German participants for five single nucleotide polymorphisms in TCF7L2. All participants underwent an OGTT; GLP-1 secretion was measured in 155 participants. In 210 participants, an IVGTT combined with a hyperinsulinaemic-euglycaemic clamp was performed. In another 160 participants from the Netherlands and 73 from Germany, a hyperglycaemic clamp (10 mmol/l) was performed. In 73 German participants this clamp was combined with a GLP-1 infusion and an arginine bolus.Results The OGTT data confirmed that variants in TCF7L2 are associated with reduced insulin secretion. In contrast, insulin secretion induced by an i.v. glucose challenge in the IVGTT and hyperglycaemic clamp was not different between the genotypes. GLP-1 concentrations during the OGTT were not influenced by the TCF7L2 variants. However, GLP-1-infusion combined with a hyperglycaemic clamp showed a significant reduction in GLP-1-induced insulin secretion in carriers of the risk allele in two variants (rs7903146, rs12255372, p < 0.02).Conclusions/interpretation Variants of TCF7L2 specifically impair GLP-1-induced insulin secretion. This seems to be rather the result of a functional defect in the GLP-1 signalling in beta cells than a reduction in GLP-1 secretion. This defect might explain the impaired insulin secretion in carriers of the risk alleles and confers the increased risk of type 2 diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-007-0753-6

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
TCF7L2 Polymorphisms and Progression to Diabetes in the Diabetes Prevention Program
Florez, J. C., Jablonski, K. A., Bayley, N., Pollin, T. I., de Bakker, P. I. W., Shuldiner, A. R., Knowler, W. C., Nathan, D. M., & Altshuler, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062418 · Cited by 834
Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo.
Deacon, C. F., Johnsen, A. H., & Holst, J. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883856 · Cited by 792
Self-citation
Glucagon-Like Peptide-1-(7–36)Amide Is Transformed to Glucagon-Like Peptide-1-(9–36)Amide by Dipeptidyl Peptidase IV in the Capillaries Supplying the L Cells of the Porcine Intestine1
Hansen, L., Deacon, C. F., Ørskov, C., & Holst, J. J. (1999) · Endocrinology · doi:10.1210/endo.140.11.7143 · Cited by 595
Self-citation
Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution
Helgason, A., Pálsson, S., Þorleifsson, G., Grant, S. F. A., Emilsson, V., Gunnarsdottir, S., Adeyemo, A., Chen, Y., Chen, G., Reynisdóttir, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1960 · Cited by 529
TCF-4 Mediates Cell Type-specific Regulation of Proglucagon Gene Expression by β-Catenin and Glycogen Synthase Kinase-3β
Yi, F., Brubaker, P. L., & Jin, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411487200 · Cited by 417
WOMEN AND MEN
Scheinfeld, A. (1945) · The American Journal of the Medical Sciences · doi:10.1097/00000441-194507000-00025 · Cited by 381
Common Single Nucleotide Polymorphisms in TCF7L2 Are Reproducibly Associated With Type 2 Diabetes and Reduce the Insulin Response to Glucose in Nondiabetic Individuals
Saxena, R., Gianniny, L., Burtt, N. P., Lyssenko, V., Giuducci, C., Sjögren, M., Florez, J. C., Almgren, P., Isomaa, B., Orho‐Melander, M., et al. (2006) · Diabetes · doi:10.2337/db06-0381 · Cited by 373
The Peroxisome Proliferator-Activated Receptor-γ2 Pro12Ala Polymorphism
Stümvoll, M., & Häring, H. U. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2341 · Cited by 329
Self-citation

Show all 30 references

Sorted by citations

Items 101–200 of 308

Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis
Dong, C. X., & Brubaker, P. L. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.185 · Cited by 45
TCF7L2variant genotypes and type 2 diabetes risk in Brazil: significant association, but not a significant tool for risk stratification in the general population
Marquezine, G. F., Pereira, A., Sousa, A., Mill, J., Hueb, W. A., & Krieger, J. E. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-106 · Cited by 44
Sulwon Lecture 2009: The Search for Genetic Risk Factors of Type 2 Diabetes Mellitus
Park, K. S. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.1.12 · Cited by 47
Translating TCF7L2: from gene to function
Pearson, E. R. (2009) · Diabetologia · doi:10.1007/s00125-009-1356-1 · Cited by 44
The T-Allele of TCF7L2 rs7903146 Associates With a Reduced Compensation of Insulin Secretion for Insulin Resistance Induced by 9 Days of Bed Rest
Alibegovic, A. C., Sonne, M. P., Højbjerre, L., Hansen, T. F., Pedersen, O. B., van Hall, G., Holst, J. J., Stallknecht, B. M., Dela, F., & Vaag, A. A. (2010) · Diabetes · doi:10.2337/db09-0918 · Cited by 45
Self-citation
Diabetes-Associated Common Genetic Variation and Its Association With GLP-1 Concentrations and Response to Exogenous GLP-1
Smushkin, G., Sathananthan, M., Sathananthan, A., Man, C. D., Micheletto, F., Zinsmeister, A. R., Cobelli, C., & Vella, A. V. (2012) · Diabetes · doi:10.2337/db11-1732 · Cited by 43
β-Cell Sensitivity to GLP-1 in Healthy Humans Is Variable and Proportional to Insulin Sensitivity
Aulinger, B. A., Vahl, T. P., Wilson, H., Prigeon, R. L., & D’Alessio, D. A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4009 · Cited by 44
Genome-wide association study for type 2 diabetes: clinical applications
Lyssenko, V., & Groop, L. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832923af · Cited by 43
Smoking-by-genotype interaction in type 2 diabetes risk and fasting glucose
Wu, P., Rybin, D. V., Bielak, L. F., Feitosa, M. F., Franceschini, N., Li, Y., Lu, Y., Marten, J., Musani, S. K., Noordam, R., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230815 · Cited by 45
The transcription factor 7-like 2 gene and increased risk of type 2 diabetes: an update
Lyssenko, V. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328304d970 · Cited by 41
Genetics of type 2 diabetes
Smushkin, G., & Vella, A. V. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833a558d · Cited by 42
Regulation of wingless-type MMTV integration site family (WNT) signalling in pancreatic islets from wild-type and obese mice
Krützfeldt, J., & Stoffel, M. (2009) · Diabetologia · doi:10.1007/s00125-009-1578-2 · Cited by 40
Alternative human liver transcripts of TCF7L2 bind to the gluconeogenesis regulator HNF4α at the protein level
NEVE, B. P., Bacquer, O. L., Caron, S., Huyvaert, M., Leloire, A., Poulain‐Godefroy, O., Lecœur, C., Pattou, F. N., Staels, B., & Froguel, P. (2014) · Diabetologia · doi:10.1007/s00125-013-3154-z · Cited by 38
Genetics of type 2 diabetes in European populations
Qi, Q., & Hu, F. B. (2012) · Journal of Diabetes · doi:10.1111/j.1753-0407.2012.00224.x · Cited by 39
Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering Medications
Fritsche, A., Heni, M., Peter, A., Gallwitz, B., Kellerer, M., Birkenfeld, A. L., Häring, H., & Wagner, R. J. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1242-9809 · Cited by 38
Self-citation
Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test
Gjesing, A. P., Kjems, L., Vestmar, M. A., Grarup, N., Linneberg, A. R., Deacon, C. F., Holst, J. J., Pedersen, O. B., & Hansen, T. F. (2010) · Diabetologia · doi:10.1007/s00125-010-1940-4 · Cited by 36
Self-citation
A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination
Garcin, C. L., & Habib, S. J. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-53150-2_15 · Cited by 40
Sodium‐glucose cotransporter‐2 inhibition improves incretin sensitivity of pancreatic β‐cells in people with type 2 diabetes
Ahn, C. H., Oh, T. J., Kwak, S. H., & Cho, Y. M. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13081 · Cited by 33
Adipocyte-specific deletion of Tcf7l2 induces dysregulated lipid metabolism and impairs glucose tolerance in mice
Nguyen‐Tu, M., Martínez-Sánchez, A., Leclerc, I., Rutter, G. A., & Xavier, G. D. S. (2020) · Diabetologia · doi:10.1007/s00125-020-05292-4 · Cited by 37
Genetic influences on the insulin response of the beta cell to different secretagogues
Simonis-Bik, A. M. C., Eekhoff, E. M. W., de Moor, M. H. M., Kramer, M. H. H., Boomsma, D. I., Heine, R. J., Dekker, J. M., Maassen, J. A., Hart, L. M. ‘., Diamant, M., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1532-3 · Cited by 34
Self-citation
Chapter 19 Role of Wnt Signaling in the Development of Type 2 Diabetes
Bordonaro, M. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00619-5 · Cited by 33
Animal Models of GWAS-Identified Type 2 Diabetes Genes
Xavier, G. D. S., Bellomo, E. A., McGinty, J., French, P. M. W., & Rutter, G. A. (2013) · Journal of Diabetes Research · doi:10.1155/2013/906590 · Cited by 33
Exendin-4 upregulates the expression of Wnt-4, a novel regulator of pancreatic β-cell proliferation
Heller, C., Kühn, M. C., Mülders-Opgenoorth, B., Schott, M., Willenberg, H. S., Scherbaum, W. A., & Schinner, S. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00144.2011 · Cited by 32
Investigation of gene–diet interactions in the incretin system and risk of type 2 diabetes: the EPIC-InterAct study
The InterAct Consortium (2016) · Diabetologia · doi:10.1007/s00125-016-4090-5 · Cited by 35
Serum Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) in association with the Risk of Gestational Diabetes: A Prospective Case-Control Study
Mosavat, M., Omar, S. Z., Jamalpour, S., & Tan, P. C. (2020) · Journal of Diabetes Research · doi:10.1155/2020/9072492 · Cited by 32
Metabolic, hormonal characteristics and genetic variants of TCF7L2 associated with development of gestational diabetes mellitus in Mexican women
Reyes‐López, R., Pérez-Luque, E. L., & Malacara, J. M. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2538 · Cited by 31
Interactions between genetic factors that predict diabetes and dietary factors that ultimately impact on risk of diabetes
Qi, L., & Liang, J. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283346cb6 · Cited by 31
Effect of TCF7L2 polymorphism on pancreatic hormones after exenatide in type 2 diabetes
Ferreira, M. C., da Silva, M. E. R., Fukui, R. T., Arruda-Marques, M. D. C., Azhar, S., & dos Santos, R. F. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0401-6 · Cited by 34
The Role of Pharmacogenetics in Drug Disposition and Response of Oral Glucose-Lowering Drugs
van Leeuwen, N., Swen, J. J., Guchelaar, H., & Hart, L. M. ‘. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0076-3 · Cited by 31
Worldwide Distribution of Type II Diabetes-Associated TCF7L2 SNPs: Evidence for Stratification in Europe
Guinan, K. J. (2011) · Biochemical Genetics · doi:10.1007/s10528-011-9456-2 · Cited by 29
Dietary Fiber Intake Modulates the Association Between Variants in TCF7L2 and Weight Loss During a Lifestyle Intervention
Heni, M., Herzberg-Schäfer, S. A., Machicao, F. E., Häring, H., & Fritsche, A. (2012) · Diabetes Care · doi:10.2337/dc11-2012 · Cited by 28
Self-citation
TCF7L2 correlation in both insulin secretion and postprandial insulin sensitivity
Ferreira, M. C., da Silva, M. E. R., Fukui, R. T., Arruda-Marques, M. D. C., & dos Santos, R. F. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0338-1 · Cited by 27
Transcription Factor-7-Like-2 (TCF7L2) in Atherosclerosis: A Potential Biomarker and Therapeutic Target
Li, J., Li, Z., Ouyang, X.-P., & He, P. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.701279 · Cited by 28
WNT signalling is both an inducer and effector of glucagon-like peptide-1
Gustafson, B., & Smith, U. (2008) · Diabetologia · doi:10.1007/s00125-008-1109-6 · Cited by 27
The risk allele load accelerates the age-dependent decline in beta cell function
Haupt, A., Staiger, H., Schäfer, S., Kirchhoff, K., Guthoff, M., Machicao, F. E., Gallwitz, B., Stefan, N., Häring, H., & Fritsche, A. (2009) · Diabetologia · doi:10.1007/s00125-008-1250-2 · Cited by 28
Self-citation
COUP-TFII Controls Mouse Pancreatic β-Cell Mass through GLP-1-β-Catenin Signaling Pathways
Boutant, M., Ramos, O. H. P., Tourrel‐Cuzin, C., Movassat, J., Ilias, A., Vallois, D., Planchais, J., Pégorier, J. P., Schuit, F. C., Petit, P. X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030847 · Cited by 28
Effects of TCF7L2 polymorphisms on glucose values after a lifestyle intervention
Bo, S., Gambino, R., Ciccone, G., Rosato, R., Milanesio, N., Villois, P., Pagano, G., Cassader, M., Gentile, L., Durazzo, M., et al. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28379 · Cited by 29
Polymorphisms of TCF7L2 and HHEX genes in Chinese women with polycystic ovary syndrome
Xu, P., Che, Y., Cao, Y., Wu, X., Sun, H., Liang, F., Sun, J., Ke, L., Yi, L., & Wang, Y. L. (2009) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-009-9377-8 · Cited by 28
Untangling the interplay of genetic and metabolic influences on beta-cell function: Examples of potential therapeutic implications involving TCF7L2 and FFAR1
Wagner, R. J., Staiger, H., Ullrich, S., Stefan, N., Fritsche, A., & Häring, H. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.001 · Cited by 26
Self-citation
Type 2 Diabetes Mellitus
Buse, J. B., Polonsky, K. S., & Burant, C. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00031-6 · Cited by 28
Nutrigenetics and nutrigenomics—A personalized approach to nutrition
Ahluwalia, M. K. (2021) · Advances in genetics · doi:10.1016/bs.adgen.2021.08.005 · Cited by 27
Plasma Metabolomics Reveal Alterations of Sphingo- and Glycerophospholipid Levels in Non-Diabetic Carriers of the Transcription Factor 7-Like 2 Polymorphism rs7903146
Then, C., Wahl, S., Kirchhofer, A., Grallert, H., Krug, S., Kastenmüller, G., Römisch‐Margl, W., Claussnitzer, M., Illig, T., Heier, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078430 · Cited by 29
Insulin treatment and high-fat diet feeding reduces the expression of three Tcf genes in rodent pancreas
Columbus, J., Chiang, Y. P., Shao, W., Zhang, N., Wang, D., Gaisano, H. Y., Wang, Q., Irwin, D. M., & Jin, T. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0044 · Cited by 25
The expression of dominant negative TCF7L2 in pancreatic beta cells during the embryonic stage causes impaired glucose homeostasis
Shao, W., Xiong, X., Ip, W., Xu, F., Song, Z., Zeng, K., Hernandez, M., Liang, T., Weng, J., Gaisano, H. Y., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.01.008 · Cited by 25
Association of transcription factor 7-like 2 (TCF7L2) gene polymorphism with posttransplant diabetes mellitus in kidney transplant patients medicated with tacrolimus
Kurzawski, M., Dziewanowski, K., Kędzierska, K., Wajda, A., Łapczuk-Romańska, J., & Droździk, M. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70595-3 · Cited by 25
Incretin and pancreatic hormone secretion in Caucasian non‐diabetic carriers of the TCF7L2 rs7903146 risk T allele
Færch, K., Pilgaard, K. A., Knop, F. K., Hansen, T. F., Pedersen, O. B., Jørgensen, T., & Holst, J. J. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01675.x · Cited by 25
Self-citation
Methylation status of vault RNA 2-1 promoter is a predictor of glycemic response to glucagon-like peptide-1 analog therapy in type 2 diabetes mellitus
Lin, C.-H., Lee, Y., Huang, Y., & Tsai, C. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001416 · Cited by 24
Insulin alters the expression of components of the Wnt signaling pathway including TCF-4 in the intestinal cells
Sun, J., Wang, D., & Jin, T. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.12.007 · Cited by 27
Expression of the diabetes‐associated gene TCF7L2 in adult mouse brain
Lee, S., Lee, C. E., Elias, C. F., & Elmquist, J. K. (2009) · The Journal of Comparative Neurology · doi:10.1002/cne.22199 · Cited by 23
Association of TCF7L2 Allelic Variations with Gastric Function, Satiation, and GLP‐1 Levels
Vázquez‐Roque, M. I., Camilleri, M., Vella, A. V., Carlson, P., Laugen, J. M., & Zinsmeister, A. R. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00284.x · Cited by 24
The enteroinsular axis may mediate the diabetogenic effects of TCF7L2 polymorphisms
Nauck, M. A., & Meier, J. J. (2007) · Diabetologia · doi:10.1007/s00125-007-0832-8 · Cited by 24
The interplay between leptin, glucocorticoids, and GLP1 regulates food intake and feeding behaviour
Perez‐Leighton, C. E., Kerr, B., Scherer, P. E., Baudrand, R. F., & Cortés, V. (2023) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.13039 · Cited by 22
Role of GNB3, NET, KCNJ11, TCF7L2 and GRL genes single nucleotide polymorphism in the risk prediction of type 2 diabetes mellitus
Rizvi, S., Raza, S. T., Rahman, Q., & Mahdi, F. (2016) · 3 Biotech · doi:10.1007/s13205-016-0572-x · Cited by 23
Tcf7l2 plays pleiotropic roles in the control of glucose homeostasis, pancreas morphology, vascularization and regeneration
Facchinello, N., Tarifeño-Saldivia, E., Grisan, E., Schiavone, M., Peron, M., Mongera, A., Ek, O., Schmitner, N., Meyer, D., Peers, B., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09867-x · Cited by 23
TCF7L2 gene variants predispose to the development of type 2 diabetes mellitus among individuals with metabolic syndrome
Katsoulis, K., Paschou, S. Α., Hatzi, E. G., Tigas, S. K., Georgiou, I. A., & Tsatsoulis, A. A. (2018) · HORMONES · doi:10.1007/s42000-018-0047-z · Cited by 22
JNK3 Is Required for the Cytoprotective Effect of Exendin 4
Ezanno, H., Pawlowski, V., Abdelli, S., Boutry, R., Gmyr, V., Kerr-Conte, J. A., Bonny, C., Pattou, F. N., & Abderrahmani, A. (2014) · Journal of Diabetes Research · doi:10.1155/2014/814854 · Cited by 25
Pharmacogenetic Interactions of Medications Administered for Weight Loss in Adults: A Systematic Review and Meta-Analysis
BouSaba, J., Vosoughi, K., Dilmaghani, S., Prokop, L. J., & Camilleri, M. (2023) · Pharmacogenomics · doi:10.2217/pgs-2022-0192 · Cited by 24
Association of TCF7L2 and ADIPOQ with Body Mass Index, Waist-Hip Ratio, and Systolic Blood Pressure in an Endogamous Ethnic Group of India
Gupta, V., Khadgawat, R., Ng, H. K. T., Walia, G. K., Kalla, L., Rao, V. R., & SACHDEVA, M. P. (2012) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2012.0051 · Cited by 22
Interactions between genetic background, insulin resistance and β‐cell function
Kahn, S. E., Suvag, S., Wright, L. A.-C., & Utzschneider, K. M. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01650.x · Cited by 23
Interaction analysis of gene variants of TCF7L2 and body mass index and waist circumference on type 2 diabetes
Li, L., Wang, J., Ping, Z., Li, Y., Wang, C., Shi, Y., Zhou, W., & Zhang, L. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.01.014 · Cited by 22
Pharmacogenomics of GLP-1 receptor agonists: Focus on pharmacological profile
Jakhar, K., Vaishnavi, S., Kaur, P., Singh, P., & Munshi, A. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175356 · Cited by 22
Glucose Metabolism in High-Risk Subjects for Type 2 Diabetes Carrying the rs7903146TCF7L2Gene Variant
Daniele, G., Gaggini, M., Comassi, M., Bianchi, C., Basta, G., Dardano, A., Miccoli, R., Mari, A., Gastaldelli, A., & Prato, S. D. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1172 · Cited by 21
rs12255372 Variant of TCF7L2 Gene Is Protective for Obesity in Mexican Children
Klünder‐Klünder, M., Mejía-Benitez, M. A., Flores‐Huerta, S., Burguete-García, A. I., Garcı́a-Mena, J., & Cruz, M. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.05.006 · Cited by 21
The LIM homeodomain protein ISL1 mediates the function of TCF7L2 in pancreatic beta cells
Shao, W., Szeto, V., Song, Z., Tian, L., Feng, Z., Nostro, M. C., & Jin, T. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0181 · Cited by 20
Functional Genomics in Pancreatic β Cells: Recent Advances in Gene Deletion and Genome Editing Technologies for Diabetes Research
Hu, M., Cherkaoui, I., Misra, S., & Rutter, G. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.576632 · Cited by 24
Nor-1, a novel incretin-responsive regulator of insulin genes and insulin secretion
Ordelheide, A., Gerst, F., Rothfuss, O. C., Heni, M., Haas, C., Thielker, I., Herzberg-Schäfer, S. A., Böhm, A., Machicao, F. E., Ullrich, S., et al. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.06.003 · Cited by 20
Self-citation
Wnt4 antagonises Wnt3a mediated increases in growth and glucose stimulated insulin secretion in the pancreatic beta-cell line, INS-1
Bowen, A., Kos, K., Whatmore, J. L., Richardson, S. J., & Welters, H. J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.130 · Cited by 20
Association of TCF7L2 SNPs with age at onset of type 2 diabetes and proinsulin/insulin ratio but not with glucagon‐like peptide 1
Silbernagel, G., Renner, W., Grammer, T. B., Hügl, S., Bertram, J., Kleber, M. E., Hoffmann, M. M., Winkelmann, B. R., März, W., & Boehm, B. O. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1194 · Cited by 19
The Inhibitory Effect of Recent Type 2 Diabetes Risk Loci on Insulin Secretion Is Modulated by Insulin Sensitivity
Haupt, A., Guthoff, M., Schäfer, S., Kirchhoff, K., Machicao, F. E., Gallwitz, B., Staiger, H., Stefan, N., Fritsche, A., & Häring, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1876 · Cited by 18
Self-citation
When does diabetes start? Early detection and intervention in type 2 diabetes mellitus
Peralta, F. G., Abreu, C., Cos, X., & Gómez‐Huelgas, R. (2020) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2019.12.004 · Cited by 20
Associations of Common Genetic Variants With Age-Related Changes in Fasting and Postload Glucose
Jensen, A. C., Barker, A., Meena Kumari, B., Brunner, E. J., Mika Kivimaki, B., Hingorani, A. D., Wareham, N. J., Tabák, Á. G., Witte, D. R., & Langenberg, C. (2011) · Diabetes · doi:10.2337/db10-1393 · Cited by 18
Delineating the regulation of energy homeostasis using hypothalamic cell models
Wellhauser, L., Gojska, N. M., & Belsham, D. D. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.09.001 · Cited by 17
Daily Yogurt Consumption Improves Glucose Metabolism and Insulin Sensitivity in Young Nondiabetic Japanese Subjects with Type-2 Diabetes Risk Alleles
Watanabe, D., Kuranuki, S., Sunto, A., Matsumoto, N., & Nakamura, T. (2018) · Nutrients · doi:10.3390/nu10121834 · Cited by 17
Challenges in diagnosing and monitoring diabetes in patients with chronic liver diseases
Silva, T. E., Ronsoni, M. F., & Schiavon, L. D. L. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.12.013 · Cited by 17
Transcription factor 7-like 2 gene links increased in vivo insulin synthesis to type 2 diabetes
Jainandunsing, S., Koole, H. R., van Miert, J. N. I., Rietveld, T., Wattimena, J. L. D., Sijbrands, E. J. G., & de Rooij, F. W. M. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.03.026 · Cited by 17
Transcription Factor 7-Like 2 (TCF7L2) Polymorphism and Hyperglycemia in an Adult Italian Population-Based Cohort
Gambino, R., Bo, S., Gentile, L., Musso, G., Pagano, G., Cavallo‐Perin, P., & Cassader, M. (2009) · Diabetes Care · doi:10.2337/dc09-1690 · Cited by 16
What Can Diabetes-Associated Genetic Variation in TCF7L2 Teach Us About the Pathogenesis of Type 2 Diabetes?
Adams, J. D., & Vella, A. V. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2018.0024 · Cited by 17
Variance of the SGK1 Gene Is Associated with Insulin Secretion in Different European Populations: Results from the TUEF, EUGENE2, and METSIM Studies
Friedrich, B., Weyrich, P., Stančáková, A., Jianjung, W., Kuusisto, J., Laakso, M., Sesti, G., Succurro, E., Smith, U., Hansen, T. F., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003506 · Cited by 15
Self-citation
Clinical and genetic predictors of diabetes drug’s response
Fodor, A., Cozma, A., Suharoschi, R., Sitar-Tăut, A., & Román, G. (2019) · Drug Metabolism Reviews · doi:10.1080/03602532.2019.1656226 · Cited by 16
Insights on effects of Wnt pathway modulation on insulin signaling and glucose homeostasis for the treatment of type 2 diabetes mellitus: Wnt activation or Wnt inhibition?
Yadav, R., & Patel, B. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129634 · Cited by 16
Potential role of TCF7L2 gene variants on cardiac sympathetic/parasympathetic activity
Boccardi, V., Ambrosino, I., Papa, M., Fiore, D., Rizzo, M. R., Paolisso, G., & Barbieri, M. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.117 · Cited by 15
Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient
Kotsis, V., Jordan, J., Stabouli, S., Antza, C., Micić, D., Jelaković, B., Schlaich, M. P., Nilsson, P. M., Kreutz, R. H., Mancia, G., et al. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002279 · Cited by 14
Lack of association between TCF7L2 gene variants and type 2 diabetes mellitus in a Brazilian sample of patients with the risk for cardiovascular disease
Wünsch, C., Dornelles, T. F., Girardi, P., Arndt, M., Genro, J. P., & Contini, V. (2019) · Endocrine Regulations · doi:10.2478/enr-2019-0001 · Cited by 14
Interactions between Intestinal Homeostasis and NAD+ Biology in Regulating Incretin Production and Postprandial Glucose Metabolism
Nagahisa, T., Kosugi, S., & Yamaguchi, S. (2023) · Nutrients · doi:10.3390/nu15061494 · Cited by 14
Clinical and non-targeted metabolomic profiling of homozygous carriers of Transcription Factor 7-like 2 variant rs7903146
Wagner, R. J., Li, J., Kenar, E., Kohlbacher, O., Machicao, F. E., Häring, H., Fritsche, A., Xu, G., & Lehmann, R. (2014) · Scientific Reports · doi:10.1038/srep05296 · Cited by 14
Self-citation
Beyond association: A functional role for Tcf7l2 in β-cell development
Migliorini, A., & Lickert, H. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.03.002 · Cited by 14
The Incretins and Pancreatic β-Cells: Use of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide to Cure Type 2 Diabetes Mellitus
Kim, M., & Lee, M. (2010) · Korean Diabetes Journal · doi:10.4093/kdj.2010.34.1.2 · Cited by 14
Recent advances in the genetics of diabetes
Pearson, E. R. (2008) · Primary care diabetes · doi:10.1016/j.pcd.2007.12.005 · Cited by 14
Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus
Song, J., Li, N., Hu, R., Yu, Y., Xu, K., Ling, H., Lü, Q., Yang, T., Wang, T., & Yin, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.949990 · Cited by 13
TCF7L2 rs7903146 Gene Variation Is Associated with Risk of Type 2 Diabetes in Turkish Population
Demirsoy, İ. H., & Aras, N. (2016) · Journal of Clinical & Medical Genomics · doi:10.4172/2472-128x.1000141 · Cited by 13
The Interaction between Genetic Polymorphisms in FTO and TCF7L2 Genes and Dietary Intake with Regard to Body Mass and Composition: An Exploratory Study
Nasreddine, L., Akika, R., Mailhac, A. C., Tamim, H., & Zgheib, N. K. (2019) · Journal of Personalized Medicine · doi:10.3390/jpm9010011 · Cited by 13
The Role of Genetic Polymorphism in the Formation of Arterial Hypertension, Type 2 Diabetes and their Comorbidity
Shalimova, A., Fadieienko, G. D., Kolesnikova, O. V., Isayeva, G., Zlatkina, V. V., Nemtsova, V. D., Prosolenko, K., Psarova, V., Kyrychenko, N., & Kochuieva, M. M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190314124049 · Cited by 13
¿Cuándo empieza la diabetes? Detección e intervención tempranas en diabetes mellitus tipo 2
Peralta, F. G., Abreu, C., Cos, X., & Gómez‐Huelgas, R. (2020) · Revista Clínica Española · doi:10.1016/j.rce.2019.12.003 · Cited by 15
Preliminary report: No association between TCF7L2 rs7903146 and euglycemic-clamp–derived insulin sensitivity in a mixed-age cohort
Rasmussen‐Torvik, L. J., Pankow, J. S., Jacobs, D. R., & Sinaiko, A. R. (2009) · Metabolism · doi:10.1016/j.metabol.2009.04.023 · Cited by 13
Clinical Impact of the TCF7L2 Gene rs7903146 Type 2 Diabetes Mellitus Risk Polymorphism in Women with Gestational Diabetes Mellitus: Impaired Glycemic Control and Increased Need of Insulin Therapy
Potasso, L., Perakakis, N., Lamprinou, A., Polyzou, E., Kassanos, D., Peter, A., Päth, G., Seufert, J., & Laubner, K. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1008-9223 · Cited by 13
Pharmacogenetics for Type 2 Diabetes: Practical Considerations for Study Design
Vella, A. V. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300415 · Cited by 13
Personalized Pharmacotherapy for Type�2 Diabetes Mellitus
Sathananthan, A., & Vella, A. V. (2009) · Personalized Medicine · doi:10.2217/pme.09.3 · Cited by 12
PROLEGOMENON TO THE EUROPEAN CONSTITUTION BOOK OF DIABETES MELLITUS
Ionescu-Tirgoviste, C., & Paulescu, N. (2008) · Cited by 12
Mutational Landscape of the Proglucagon-Derived Peptides
Lindquist, P., Madsen, J. S., Bräuner‐Osborne, H., ROSENKILDE, M. M., & Hauser, A. S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.698511 · Cited by 13
Therapy with oral antidiabetic drugs: applied pharmacogenetics
Holstein, A., Seeringer, A., & Kovacs, P. L. (2011) · The British Journal of Diabetes · doi:10.1177/1474651410397583 · Cited by 12

Authors: Schäfer, S. A., Tschritter, O., Machicao, F., Thamer, C., Stefan, N., Gallwitz, B., Holst, J. J., Dekker, J. M., t’Hart, L. M., Nijpels, G., van Haeften, T. W., Häring, H. U., & Fritsche, A.
Affiliations: University of Tübingen (DE)
University of Copenhagen (DK)
Amsterdam Public Health (NL)
Corresponding author: Fritsche, A.
ORCID: Stefan, N.
Gallwitz, B.
Holst, J. J.
Nijpels, G.
Fritsche, A.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2007-07-28
Volume: 50
Issue: 12
Pages: 2443-2450
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-007-0753-6
PMC: PMC2063563
OpenAlex: W2132717133
Cited by: 308
References: 30
Citations by year: 2026: 3 · 2025: 5 · 2024: 7 · 2023: 5 · 2022: 9 · 2021: 8 · 2020: 11 · 2019: 18 · 2018: 14 · 2017: 10 · 2016: 15 · 2015: 15 · 2014: 26 · 2013: 17 · 2012: 23
FWCI: 32.85
Type: journal article
Language: en
Update notices: correction (2007-11-10)
correction (2009-01-08)
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
VU Research Portal (publishedVersion, other-oa)
Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders: Deutsche Forschungsgemeinschaft (KFO 114)
ZonMw
Centre for Medical Systems Biology
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords: TCF7L2, glucagon-like peptide-1, insulin secretion, type 2 diabetes risk, single nucleotide polymorphisms, enteroinsular axis, GLP-1 secretion, GLP-1 receptor, rs7903146, rs12255372, risk alleles
MeSH terms: Insulin Secretion, Adult, Arginine, Blood Glucose, Female, Glucose Tolerance Test, Heterozygote, Humans, Insulin, Insulin Resistance, Male, Middle Aged, Glucose Clamp Technique, Glucose Intolerance, Polymorphism, Single Nucleotide, TCF Transcription Factors, Glucagon-Like Peptide 1, Transcription Factor 7-Like 2 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks